TheEdgeResearch
Home / Stocks / IMMPF

ImmuPharma plc (IMMPF)

OTC Healthcare Biotechnology
$0.09 ▲ +0.00%
Market Cap
$28.3M
Sector
Healthcare
Industry
Biotechnology
Beta
1.41
52-Wk Range
0.08-0.085
CEO
Timothy Paul McCarthy XIV, FCCA, MBA
Country
GB
Currency
USD

ImmuPharma plc operates in the Biotechnology industry of the Healthcare sector, headquartered in London, GB. The stock last traded at $0.09, up 0.00% on the session, giving a market capitalisation of $28.3M. Its beta of 1.41 implies it has historically moved more than the broad market.

Company profile
Exchange
Other OTC
Employees
14
IPO date
2017-02-08
Headquarters
London, GB
About ImmuPharma plc

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom. Its peptide-based therapeutics focuses on autoimmunity and inflammation, and anti-infectives therapeutic areas. The company’s lead product candidate includes P140, a peptide technology platform, which is in Phase III clinical trial that targets autoimmune diseases for systemic lupus erythematosus; P140, which is in Phase II clinical trial for the treatment of chronic inflammatory demyelinating polyneuropathy, a rare acquired autoimmune disorder of peripheral nerve; and P140 that covers other indications acute and chronic asthma, gout, irritable bowel disease, and periodontitis. Its pre-clinical products include BioAMB, a peptide-based drug of Amphotericin-B formulations for the treatment of serious and life-threatening fungal infections, such as aspergillosis; and BioCin, a vancomycin based treatment for anti-infection. It has a collaboration arrangement with Centre National de la Recherche Scientifique for the development of 1P40 platform; and license and development agreement with Avion Pharmaceuticals LLC. ImmuPharma plc was founded in 1999 and is headquartered in London, the United Kingdom.

Comparable companies

ImmuPharma plc is most often compared with the following Healthcare names:

ACOGFCHBRFDMTTFEMMLFGENHIBXNFIGXTKMSTFLSBCFOCEL
More research on IMMPF
IMMPF technical analysis IMMPF TheEdge Score Compare against peers
Open full interactive analysis & DCF →